Stay updated on AXA4010 Safety in Sickle Cell Disease Clinical Trial

Sign up to get notified when there's something new on the AXA4010 Safety in Sickle Cell Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AXA4010 Safety in Sickle Cell Disease Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.0 to v3.6.3, indicating a newer version of the page has been published. This suggests a minor update to the page metadata or content.
    Difference
    0.1%
    Check dated 2026-07-01T09:23:21.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Recruitment status on the study page now indicates no longer looking for participants. New user guidance sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the Intervention/Treatment label formatting plus the page revision to v3.6.0 (from v3.5.4) were updated.
    Difference
    0.5%
    Check dated 2026-06-09T19:56:24.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.5.3 to v3.5.4, indicating a small backend/format update; no visible changes to the study details are expected.
    Difference
    0.1%
    Check dated 2026-05-19T11:26:56.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    The page shows a revision tag changing from v3.5.2 to v3.5.3, indicating a small administrative update to the ClinicalTrials.gov record.
    Difference
    0.1%
    Check dated 2026-04-27T19:36:19.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-20T15:40:21.000Z thumbnail image
  8. Check
    98 days ago
    Change Detected
    Summary
    Hb SS disease added under Resources and Genetic and Rare Diseases Information Center listed as a Resources reference.
    Difference
    0.2%
    Check dated 2026-03-30T02:00:30.000Z thumbnail image

Stay in the know with updates to AXA4010 Safety in Sickle Cell Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AXA4010 Safety in Sickle Cell Disease Clinical Trial page.